MARATTO

article · Zagazig Nursing Journal

Knowledge, Associated Factors, and Adverse Outcomes of Polypharmacy Among Elderly Patients

2024Open accessZagazig University

Abstract

Background: Polypharmacy, particularly in the elderly, is a formidable global public health problem that increases hospitalization, lowers quality of life, and represents an economic burden. Aim of the study: Assess knowledge, associated factors, and adverse outcomes of polypharmacy among elderly patients. Subjects and Methods; Design: A descriptive design was utilized. Setting: The study was carried out at Zagazig University Hospitals’ outpatient clinics. Subjects: Purposive sample composed of 200 elderly patients. Tools of data collection: Tool I: A structured interview questionnaire. Tool II: Elderly’s knowledge of polypharmacy interview questionnaire. Tool III: Associated factors of polypharmacy interview questionnaire. Tool IV: Polypharmacy Adverse outcomes interview questionnaire. Results: 92% of the studied elderly had poor score of knowledge regarding polypharmacy, 77.5% had high associated factors, and 63% had high adverse outcomes. Conclusion: A statistically significant negative correlation was found between polypharmacy knowledge and associated factors, and between knowledge and adverse outcomes. Conversely, there was a statistically significant positive correlation between polypharmacy associated factors and adverse outcomes. Recommendation: Designing educational programs to increase medication awareness and familiarity among older adults, to improve health outcomes with fewer prescriptions needed.

Research topics

  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacy and Medical Practices

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/znj.2024.369040

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.